Button - go to Our Firm page
Button - go to Attorney Profiles page
Button - go to Contact page
 
Graphic: Search our site   

Photo - Gavel and Law Books
Return to Home Page
Link to Our Offices page
Link to Current Cases page
Link to Practice Areas page
Link to Media Center page
Link to Articles page
Link to News page
Link to About Class Actions page
Link to Class Notices
Link to Newsletter page
Link to Public Interest Cases page
Link to Trial Experience page
Link to Legal Links page
Link to Employment page
Link to Disclaimer page
Link to Privacy Policy page
Link to Site Map page
 
  

U.S. Supreme Court (continued)

Page 2
Is the general welfare the enemy of the general health, which would be improved by cigarette regulation. The majority knows "that tobacco products are addicting in much the same way as heroin and cocaine, and that nicotine is the drug that causes addiction." However, it grants nicotine amnesty from the war on drugs. In the majority's version of Congressional reality, where the public is squared off against the tobacco industry, the enemy is not it, but us. The court seems to be saying that tobacco is special and more deserving of protection than the lives and health of our people, referencing "the economic and political significance of the tobacco industry" in explaining its view of Congress's immunizing intent. Congress may be hazardous to your health.
As the dissent -- author Justice Breyer joined by Stevens, Souter and Ginsberg -- points out, it is only recently that the FDA has obtained evidence sufficient to prove the intent of the tobacco industry to market nicotine cigarettes as a drug. Surely old politics should not trump new evidence.
Although the Supreme Court leaves it to Congress to manifest a new regulatory intent, the failure of congressional initiatives to resolve tobacco claims has demonstrated the strong hold that the industry retains on Congress.
This leaves private litigation. Public litigation, in the form of government entity suits, proved successful in recouping much of the public's cost of treating tobacco-related disease and in obtaining youth marketing restrictions. However, the industry still has paid not one penny to any smoker on individual injury claims, despite several jury verdicts and punitive damage awards.
Even the most successful smokers' trial lawyers are not taking on individual tobacco cases in the wake of these recent victories, because smoker’s suits are too costly to win. The tobacco industry still successfully deploys its strategy of attrition to protect, on the private front, the immunity the Supreme Court has now affirmed on the regulatory front.
It is time for those engaged in private litigation to take up the torch passed by lawyers heroically engaged in individual smoker's suits, to establish tobacco industry accountability.
1 | 2
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP is a fifty-plus attorney law firm that has represented plaintiffs nationwide since 1972. We have offices in San Francisco, New York and Nashville. We represent plaintiffs in class and group actions and in individual lawsuits in cases involving substantial losses. For the last six years, the National Law Journal has selected Lieff Cabraser as one of the top plaintiffs' law firms in the nation.
Notice
This website is sponsored by Lieff Cabraser Heimann & Bernstein, LLP, a national plaintiffs' law firm.

Our offices
LIEFF CABRASER HEIMANN & BERNSTEIN, LLP
E-Mail: mail@lchb.com
Firm Website: www.lieffcabraser.com


Notice: Lieff Cabraser attorneys provide legal advice and practice law for clients in federal district courts throughout the United States and in state courts where we are licensed to practice. In states in which our lawyers are not licensed to practice, we have affiliations with local attorneys who serve as co-counsel with our firm. Please read our disclaimer.

Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP